“breast-cancer” Archives

in
Entry Author Date Location
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
San Diego Life Sciences Roundup: Halozyme, Pathway Genomics, Avanir 07/03/13 San Diego
San Diego Life Sciences Roundup: Aragon, Santarus, Tocagen, and More 06/20/13 San Diego
Hollywood Celebrates Breast Cancer Genetics Pioneer Mary-Claire King 05/15/13 Seattle
Genomic Health Test Aims To Cut Overtreatment of Prostate Cancer 05/08/13 San Francisco
Ziopharm Goes Lean to Stretch Funds for New Synthetic Biology Focus 04/09/13 New York
San Diego’s Ambrx Working with Astellas to Develop Anti-Cancer Drugs 04/08/13 San Diego
Why Are Healthcare Costs Exploding? See Proton Cancer Therapy 03/18/13 National
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Sanitas Gets FDA Clearance to Market ‘Wellaho’ for Chronically Ill 02/20/13 San Diego
NanoString Starts Selling First Breast Cancer Test in EU 02/19/13 Seattle
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
NanoString Gets EU Clearance To Sell Breast Cancer Diagnostic Test 09/27/12 Seattle
Genentech, ImmunoGen Breast Cancer Drug Extends Lives 08/27/12 San Francisco
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Will 3-D Thermal Imaging Revolutionize Breast Cancer Detection? 05/18/12 Detroit Ann Arbor
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle 03/30/12 San Francisco
Genoa Pharma Aims To Satisfy Big Pharma’s Hunger for IPF Drugs 03/30/12 San Diego
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers 03/06/12 San Diego
NanoString Nails Breast Cancer Study, Challenging Genomic Health 12/08/11 Seattle
Genentech’s Two-Drug Strategy Raises the Bar in Breast Cancer 12/07/11 San Francisco
Genomic Health Wins Medicare Coverage for High-Priced Colon Cancer Test 09/30/11 San Francisco
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine 09/13/11 Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial 09/06/11 Boston
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug 08/22/11 Seattle
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment 07/05/11 Boston
This Drug Didn’t Work for Me. May I Have My $88,000 Back, Please? 06/30/11 Seattle
Page 2 of 4 « previous page · next page »